Correspondence 0001104659-23-061876 from Applied Therapeutics, Inc. (APLT) (CIK 0001697532)
Applied Therapeutics, Inc. (APLT) (CIK 0001697532)
Date: May 17, 2023 · CIK: 0001697532 · Accession: 0001104659-23-061876
AI Filing Summary & Sentiment
File numbers found in text: 333-271887
Letter
Applied Therapeutics, Inc.
545 Fifth Avenue, Suite 1400
New York, New York 10017
May 17, 2023
VIA EDGAR AND EMAIL
Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, D.C. 20549
Attn: Tim Buchmiller
Re: Applied Therapeutics, Inc.
Registration Statement on Form S-3 (File No. 333-271887)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
We refer to the registration statement on Form S-3 (File No. 333-271887) (the “Registration Statement”), of Applied Therapeutics, Inc. (the “Company”).
In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effectiveness of the Registration Statement be accelerated so that it may become effective at 4:00 p.m. (Eastern time) on Friday, May 19, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Please call Michael J. Schwartz of Skadden, Arps, Slate, Meagher & Flom LLP, at (212) 735-3694, to confirm the effectiveness of the Registration Statement.
Very
truly yours,
Applied Therapeutics, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Applied Therapeutics, Inc.
545 Fifth Avenue, Suite 1400
New York, New York 10017
May 17, 2023
VIA EDGAR AND EMAIL
Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, D.C. 20549
Attn: Tim Buchmiller
Re: Applied Therapeutics, Inc.
Registration Statement on Form S-3
(File No. 333-271887)
Request for Acceleration of Effective
Date
Ladies and Gentlemen:
We refer to the registration statement on Form S-3
(File No. 333-271887) (the “Registration Statement”), of Applied Therapeutics, Inc. (the “Company”).
In accordance with Rules 460 and 461 under the
Securities Act of 1933, as amended, the Company hereby respectfully requests that the effectiveness of the Registration Statement be accelerated
so that it may become effective at 4:00 p.m. (Eastern time) on Friday, May 19, 2023, or at such later time as the Company or
its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Please call Michael J. Schwartz of Skadden, Arps,
Slate, Meagher & Flom LLP, at (212) 735-3694, to confirm the effectiveness of the Registration Statement.
Very
truly yours,
Applied Therapeutics, Inc.
By:
/s/ Shoshana Shendelman
Name:
Shoshana Shendelman
Title:
President and Chief Executive Officer
(Principal Executive Officer)